Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-25

Clinical Trial Update: Cabergoline Effect on Blood Sugar in Type 2 Diabetics [NA]

View source ↗

Summary

A clinical trial assessing the effect of cabergoline on blood sugar in patients with type 2 diabetes; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Diabetes Type 2 | NA | Status: UNKNOWN